| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |